Daily Medical News

Dr. Joseph Murray of the Mayo Clinic points out that you might know as much about celiac as you think (http://bit.ly/2preFr4). Also today, a novel agent shows unprecedented efficacy in psoriasis (http://bit.ly/2MLLE2I), IgA vasculitis may be more common in adults than you think (http://bit.ly/2DeXTFC), and one-step gestational diabetes screening doesn’t improve outcomes (http://bit.ly/2xy7VLM).

The U.S. Preventative Services Task Force advises clinicians to refer or offer intensive behavioral weight-loss interventions to obese adults (http://bit.ly/2DbYO9F). Also today, stop treating gout and start curing it (http://bit.ly/2QIhaBO) the FDA has a new risk evaluation mitigation strategy for immediate-release opioids (http://bit.ly/2Df9AvY), and the United Nations aims to eradicate tuberculosis by the year 2030 (http://bit.ly/2DenEFN).

Researchers found evidence of impaired white matter integrity on MRI in a handful of hypertensive children similar to what is found in adults with cognitive impairment from hypertension. Also today, predictors for worse outcomes in low–disease activity RA remain tough to come by, elevated type 2 diabetes risk seen in PsA patients, and new European hypertension guidelines target most adults to less than 130/80 mm Hg.

Most patients with type 2 diabetes stop taking their medication within a year, and nearly one-third stop within the first 3 months (http://bit.ly/2QD0U4U). Also today, the FDA approves Ajovy for migraine prevention(http://bit.ly/2Nhbxwq), some teens are using cannabis in their vapor devices (http://bit.ly/2pekqs7), and alpha-blocker use is still common and still risky (http://bit.ly/2No2QAE).

Urine drugs screens show improper medication use

Physician burnout singes patient safety

Sprain an ankle, get an opioid

Can tai chi tame seniors' fall risk?

Colonoscopy: Should 45 be the new 50?

Fluoroquinolones are recommended for adults with cancer-related immunosuppression. Also today, statins are not preventative in the elderly unless they have diabetes, children born from ART have risk for arterial hypertension, and Supreme Court nominee Judge Kavanaugh testifies on Roe v. Wade.

Single-dose influenza drug baloxavirhas similar efficacy to oseltamivir, according to new data in the New England Journal of Medicine. Also today, the relationship between obstructive sleep apnea and gout, community-based therapy for asthma in African American teens, and the importance of hospital settings for pneumonia.

Diclofenac has emerged as a clear culprit in higher risk for adverse cardiovascular events. Also today, the majority of e-cigarette users are under 35 years of age, a hospital dropped length of stay for neonatal abstinence syndrome, and physician groups continue to call for CMS to drop evaluation and management proposal.

Patients with non-alcoholic fatty liver disease who consumed modest quantities of alcohol had significantly less improvement in NASH. Also today, new AGA guidelines on opioid-induced constipation, a self-management intervention for epilepsy improves quality of life, and fewer enrollees reach the Medicare drug donut hole.

The FDA approves the once-daily oral drugs Delstrigo and Pifeltro for HIV-1 infection. Also today, emicizumab beats factor VIII prophylaxis by a wide margin, orodental issues are often associated with facial port-wine stains, and epilepsy often accompanies congenital Zika infections.

Both low-dose and full-dose rivaroxaban had superior benefit-risk profiles for extended VTE compared with aspirin. Also today, bone biopsy diagnostics for osteomyelitis vary widely, variation in bacterial drug susceptibility are tied to the risk of TB relapse, and CTA cuts MIs in patients with stable chest pain.